Rex Bionics

About:

REX is a hands-free, self supporting, independently controlled, robotic mobility device.

Website: http://www.rexbionics.com

Twitter/X: rexbionicsnews

Top Investors: Sante Ventures, Callaghan Innovation, BioScience Managers Limited, MRCF Biomedical Translation Fund

Description:

Rex Bionics Plc is engaged in the research and development, manufacture, and commercialization of robotic devices designed to provide physiotherapy to and improve the physical and psychological well-being of people with mobility impairment as a result of spinal cord injury or other neurological trauma, such as stroke or traumatic brain injury, or neurodegenerative disease. The Company develops and commercializes ReX, the hands-free, self-supporting, independently controlled robotic walking device for use in the rehabilitation of people with major mobility impairment. The Company offers two principal products: ReX and ReX P (Personal), which are targeted respectively at the professional neuro-rehabilitation clinic and personal homecare markets. The Company utilizes RAPPER II, which is an open label, single arm, non-randomized, non-comparative registry study of Robot-Assisted Physiotherapy Exercises with the REX Robot powered exercise system preventing unsupported patient ambulation.